Glenmark Pharms Inc Company Profile
✉ Email this page to a colleague
What is the competitive landscape for GLENMARK PHARMS INC, and what generic and branded alternatives to GLENMARK PHARMS INC drugs are available?
GLENMARK PHARMS INC has eighteen approved drugs.
Drugs and US Patents for Glenmark Pharms Inc
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Glenmark Pharms Inc | NIZATIDINE | nizatidine | CAPSULE;ORAL | 090618-002 | Jul 15, 2011 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Glenmark Pharms Inc | BETAMETHASONE DIPROPIONATE | betamethasone dipropionate | CREAM, AUGMENTED;TOPICAL | 078930-001 | Sep 23, 2008 | AB | RX | No | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Glenmark Pharms Inc | NIZATIDINE | nizatidine | CAPSULE;ORAL | 090618-001 | Jul 15, 2011 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.